PURINE/PYRIMIDINE THERAPY IN A DISORDER OF NUCLEOTIDE METABOLISM

嘌呤/嘧啶治疗核苷酸代谢紊乱

• 批准号: 5221256
• 负责人: ALICE L YU
• 金额: --
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/5221256
• 关键词: ataxia; child (0-11); clinical research; diet therapy; eye coordination disorder; generalized seizures; human subject; immunodeficiency; metabolism disorder; metabolism disorder chemotherapy; nucleotide metabolism; purines; pyrimidines; ribose; speech disorders; thymidine; uridine

To determine the potential beneficial effects of oral ribose therapy in patients who have not been placed on uridine/thymidine therapy, to test beneficial effects of adding or switching to uridine in patients, and to determine the potential benefit of adding oral ribose to patients who are currently on uridine/thymidine therapy.

目的：确定口服核糖疗法对慢性阻塞性肺疾病的潜在益处。 未接受尿苷/胸苷治疗的患者，进行测试 在患者中添加或改用尿苷的益处，以及 确定向以下患者添加口服核糖的潜在益处 目前正在接受尿苷/胸苷治疗。